Tag Archives | XLV

ETFs and Tax Savings

Investors seeking to recognize losses on stocks or bonds may find exchange traded funds a handy portfolio substitute. Jonathan Burton writes that ETFs are great portfolio placeholders because they are low cost, liquid and match almost any desired exposure. ¬†Another benefit is that ETFs do not charge the short term holding penalty that is levied […]

Biotech Gets a Strong Buy from S&P

The outlook for biotech stocks got a boost from Standard & Poor’s Equity Research team which recently upgraded its outlook for the industry to positive from neutral. According to Investment News, S&P’s biotechnology equity analyst thinks the industry is positioned for renewed investor interest in 2010, despite lagging the market in 2009.¬† The research firm […]

Traders Hedging ETF Positions with Options

Traders have recently been buying put options on some popular exchange traded funds according to the WSJ‘s Tennille Tracy. In the article Buyers Like Options on ETFs,Tracy writes that traders are taking advantage of a drop in volatility levels to buy January 2011 put options on the Technoogy Select Sector SPDR Fund (XLK). ¬† Other […]

Powered by WordPress. Designed by Woo Themes